Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?

Recruiting Observational Study
Long COVID Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
York University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Millions have developed Long COVID (LC), and recent findings show an association between taurine deficiency (an amino acid) and symptoms in LC. Cost-effective and accessible interventions are needed to improve welfare and reduce healthcare costs. We will investigate the efficacy of 12-weeks of taurine supplementation (self-administered), on vascular function and the cardio/cerebrovascular response…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Participants will have had symptoms of Long COVID post-infection for at least 3 months Exclusion Criteria: * Inability to undergo tilt table testing for 5 minutes * Inability to transport selves to York University from their homes * Inability to speak English, or provide a t…
Contacts

Heather Edgell, PhD

14167362100

edgell@yorku.ca

CONTACT